Skip to main content

ADVERTISEMENT

Michael S. Lee, MD, DPM, FACFAS, FACC, FSCAI

08/01/2008
Minimally invasive direct coronary artery bypass (MIDCAB) has been successfully used to treat isolated lesions of the left anterior descending (LAD) artery by operating on the beating heart without cardiopulmonary bypass (CPB) with excellent...
Minimally invasive direct coronary artery bypass (MIDCAB) has been successfully used to treat isolated lesions of the left anterior descending (LAD) artery by operating on the beating heart without cardiopulmonary bypass (CPB) with excellent...
Minimally invasive direct...
08/01/2008
Journal of Invasive Cardiology
Impact of Sex on Outcomes Among Patients With Cardiac Allograft Vasculopathy Who Undergo Percutaneous Coronary Intervention
12/01/2020
Orthotopic heart transplantation is a reasonable treatment strategy for patients with end-stage heart failure. Percutaneous coronary intervention (PCI) can be performed to treat cardiac allograft vasculopathy (CAV). We sought to examine...
Orthotopic heart transplantation is a reasonable treatment strategy for patients with end-stage heart failure. Percutaneous coronary intervention (PCI) can be performed to treat cardiac allograft vasculopathy (CAV). We sought to examine...
Orthotopic heart transplantation...
12/01/2020
Journal of Invasive Cardiology
Original Contribution
09/01/2009
ABSTRACT: Background. Reports of stent thrombosis and death in patients who have received drug-eluting stents (DES) have provoked debate regarding their long-term safety. We investigated the specific causes of death in patients receiving DES...
ABSTRACT: Background. Reports of stent thrombosis and death in patients who have received drug-eluting stents (DES) have provoked debate regarding their long-term safety. We investigated the specific causes of death in patients receiving DES...
ABSTRACT: Background. Reports of...
09/01/2009
Journal of Invasive Cardiology
Original Contribution
10/23/2017
Orbital atherectomy modifies calcified plaque, thereby facilitating stent delivery and stent expansion. The ideal antithrombotic agent during orbital atherectomy is unknown. We compared the angiographic and clinical outcomes of heparin and...
Orbital atherectomy modifies calcified plaque, thereby facilitating stent delivery and stent expansion. The ideal antithrombotic agent during orbital atherectomy is unknown. We compared the angiographic and clinical outcomes of heparin and...
Orbital atherectomy modifies...
10/23/2017
Journal of Invasive Cardiology
Original Contribution
03/30/2018
We report the 1-year outcomes of real-world patients with severely calcified coronary arteries who underwent orbital atherectomy.
We report the 1-year outcomes of real-world patients with severely calcified coronary arteries who underwent orbital atherectomy.
We report the 1-year outcomes of...
03/30/2018
Journal of Invasive Cardiology
ORIGINAL CONTRIBUTION
10/24/2019
OA is an effective tool to modify calcified plaque prior to stenting. However, advancement of the OA crown may be technically challenging due to complex coronary anatomy. We report our initial experience with GlideAssist to facilitate...
OA is an effective tool to modify calcified plaque prior to stenting. However, advancement of the OA crown may be technically challenging due to complex coronary anatomy. We report our initial experience with GlideAssist to facilitate...
OA is an effective tool to...
10/24/2019
Journal of Invasive Cardiology
08/01/2008
Unfractionated heparin is the primary anticoagulant administered prior to percutaneous coronary intervention (PCI) to prevent the generation of thrombin at the site of balloon-induced arterial injury and to reduce the thrombogenicity of the...
Unfractionated heparin is the primary anticoagulant administered prior to percutaneous coronary intervention (PCI) to prevent the generation of thrombin at the site of balloon-induced arterial injury and to reduce the thrombogenicity of the...
Unfractionated heparin is the...
08/01/2008
Journal of Invasive Cardiology
11/23/2019
The impact of platelet reactivity on periprocedural myonecrosis (PMN) in East Asian patients with stable ischemic heart disease or non-ST elevation ACS undergoing PCI is unclear. Achievement of optimal platelet reactivity may decrease the...
The impact of platelet reactivity on periprocedural myonecrosis (PMN) in East Asian patients with stable ischemic heart disease or non-ST elevation ACS undergoing PCI is unclear. Achievement of optimal platelet reactivity may decrease the...
The impact of platelet...
11/23/2019
Journal of Invasive Cardiology
Original Contribution
06/29/2012
Abstract: Objective. The aim of this study was to assess the clinical outcomes of percutaneous coronary intervention (PCI) with everolimus-eluting stents (EES) for the treatment of unprotected left main coronary artery (ULMCA) disease....
Abstract: Objective. The aim of this study was to assess the clinical outcomes of percutaneous coronary intervention (PCI) with everolimus-eluting stents (EES) for the treatment of unprotected left main coronary artery (ULMCA) disease....
Abstract: Objective. The aim of...
06/29/2012
Journal of Invasive Cardiology
Review
03/01/2016
Coronary artery perforation (CAP) is a rare but serious complication of percutaneous coronary intervention. We review the risk factors, common causes, complications, and treatment options for CAP. 
Coronary artery perforation (CAP) is a rare but serious complication of percutaneous coronary intervention. We review the risk factors, common causes, complications, and treatment options for CAP. 
Coronary artery perforation...
03/01/2016
Journal of Invasive Cardiology